{
  "id": "2cb553b1353e8fe0",
  "title": "Eisai Maintains Commitment to People Living with Early Alzheimer Disease Despite CDA - AMC Draft Recommendation : Patients Deserve Access to Effective Treatment",
  "description": "20260219T170000Z",
  "content": "",
  "source": "cantechletter.com",
  "source_url": "https://www.cantechletter.com/newswires/eisai-maintains-commitment-to-people-living-with-early-alzheimers-disease-despite-cda-amc-draft-recommendation-patients-deserve-access-to-effective-treatment/",
  "published_at": "20260219T170000Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "Canada",
  "raw_data": {
    "url": "https://www.cantechletter.com/newswires/eisai-maintains-commitment-to-people-living-with-early-alzheimers-disease-despite-cda-amc-draft-recommendation-patients-deserve-access-to-effective-treatment/",
    "url_mobile": "",
    "title": "Eisai Maintains Commitment to People Living with Early Alzheimer Disease Despite CDA - AMC Draft Recommendation : Patients Deserve Access to Effective Treatment",
    "seendate": "20260219T170000Z",
    "socialimage": "https://www.cantechletter.com/wp-content/uploads/Eisai_Limited_Eisai_Maintains_Commitment_to_People_Living_with_E.jpg",
    "domain": "cantechletter.com",
    "language": "English",
    "sourcecountry": "Canada"
  }
}